Furthermore, JAKi may not effectively inhibit the inflammatory SPP1+ and S100A12+ subpopulations, indicating that alternative strategies, such as TNF or JNK inhibition, might be necessary for comprehensive targeting of all inflammatory macrophage subsets in RA. The gene discussed is TNF; the disease is rheumatoid arthritis.